var data={"title":"Medium chain triglycerides: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Medium chain triglycerides: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6517?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=medium-chain-triglycerides-patient-drug-information\" class=\"drug drug_patient\">see &quot;Medium chain triglycerides: Patient drug information&quot;</a> and <a href=\"topic.htm?path=medium-chain-triglycerides-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Medium chain triglycerides: Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191959\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Betaquik [OTC];</li>\n      <li>Liquigen [OTC];</li>\n      <li>MCT Oil [OTC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191960\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>MCT Oil</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191967\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Nutritional Supplement</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191961\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cystic fibrosis</b> (MCT Oil): Oral: 45 mL daily in divided doses</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Dietary supplement</b> (MCT Oil): Oral: 15 to 20 mL per dose (maximum daily dose: 100 mL)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191964\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=medium-chain-triglycerides-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Medium chain triglycerides: Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Nutritional supplement</b> (MCT Oil): Infants: Oral: Initial: 0.5 mL every other feeding, then advance to every feeding, then increase in increments of 0.25 to 0.5 mL/feeding at intervals of 2 to 3 days as tolerated </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Seizures</b> (MCT Oil): Children: Oral: About 40 mL with each meal or 50% to 70% (800 to 1,120 kcal) of total calories (1,600 kcal) as the oil will induce ketosis necessary for seizure control </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cystic fibrosis</b> (MCT Oil): Children: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191962\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26251912\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26251913\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191949\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Emulsion, Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Betaquik: (225 mL, 250 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Liquigen: (250 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Oil, Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">MCT Oil: (946 mL)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191939\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191951\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;display:inline\">Shake emulsions well before use. May be mixed with beverages (eg, juice, milk) or mixed into sauces, salad dressings, or other foods. For administration of MCT Oil through a feeding tube, administer 15 mL via syringe through tube; flush with 30 mL of water after administration.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Possible gastrointestinal side effects from medication may be minimized if therapy is introduced gradually and ingested slowly (Gracey, 1970; Ruppin, 1980). </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191950\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Dietary supplement:</b> A medical food for use in the nutritional management of patients who cannot efficiently digest and absorb conventional long chain food fats </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191945\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Endocrine &amp; metabolic: Decreased HDL cholesterol (&gt;6 months daily use), increased serum triglycerides (&gt;6 months daily use)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Abdominal cramps, abdominal pain, bloating, diarrhea, nausea</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23601962\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Diabetic ketoacidosis: Avoid use in patients with uncontrolled diabetic ketoacidosis.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hepatic impairment: Use with caution in patients with hepatic cirrhosis; large amounts of medium chain triglycerides (MCT) may elevate blood and spinal fluid levels of medium chain fatty acids (MCFA) due to impaired hepatic clearance of MCFA (Gracey, 1970; Morgan, 1974). </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Appropriate use: These products are medical foods and should be used under medical supervision. Medium chain triglycerides are not intended as a sole source of nutrition; they do not provide the recommended daily dosage of essential fatty acids. Not for parenteral use. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191954\" class=\"block dic drugH1Div\"><span class=\"drugH1\">Dietary Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">May be taken with meals; may be mixed with beverages (eg, juice, milk) or foods (eg, sauces, salad dressings). Possible gastrointestinal side effects from medication can be prevented if therapy is initiated with small supplements at meals and gradually increased according to patient's tolerance (Gracey, 1970). </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191942\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">MCTs are saturated fatty acids in chains of 6-12 carbon atoms. They are water soluble and can pass directly through intestinal cell membranes into portal venous blood. Unlike long chain fats, MCTs do not require the presence of bile acids and pancreatic lipase for absorption. MCTs provide a source of calories while reducing the amount of malabsorbed fat remaining in stool (Gracey, 1970; Ruppin, 1980). </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46103763\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Onset of action: Octanoic acid appeared in each subject by 30 minutes following ingestion; effect on seizures in children: Within 6 weeks</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Absorption: Up to 30% of dose can be absorbed unchanged as a triglyceride in the mucosal cell</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Metabolism: Almost entirely oxidized by the liver to acetyl CoA fragments and to carbon dioxide; little deposited in adipose tissue or elsewhere</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Excretion: As much as 20% of oral dose of MCT, recovered in expired CO2 in 50 minutes; &lt;10% elimination of medium chain fatty acids in feces</p></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Beta Quick (medium chain triglycerides) [prescribing information]. Alexandria, VA: Vitaflo USA LLC; received July 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Gracey M, Burke V, Anderson CM. Medium chain triglycerides in paediatric patients. <i>Arch Dis Child</i>. 1970;45(242):445-452.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/medium-chain-triglycerides-drug-information/abstract-text/4918706/pubmed\" target=\"_blank\" id=\"4918706\">4918706</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Huttenlocher PR, Wilbourn AJ, and Signore JM. Medium-Chain Triglycerides as a Therapy for Intractable Childhood Epilepsy. <i>Neurology</i>. 1971;21(11):1097-1103.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/medium-chain-triglycerides-drug-information/abstract-text/5166216/pubmed\" target=\"_blank\" id=\"5166216\">5166216</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Morgan MH, Bolton CH, Morris JS, Read AE. Medium chain triglycerides and hepatic encephalopathy. <i>Gut</i>. 1974;15(3):180-184.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/medium-chain-triglycerides-drug-information/abstract-text/4841275/pubmed\" target=\"_blank\" id=\"4841275\">4841275</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ruppin DC, Middleton WRJ. Clinical use of medium chain triglycerides. <i>Drugs</i>. 1980;20(3): 216-224.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/medium-chain-triglycerides-drug-information/abstract-text/7428670/pubmed\" target=\"_blank\" id=\"7428670\">7428670</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 10132 Version 59.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F191959\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F191960\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F191967\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F191961\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F191964\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F191962\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F26251912\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F26251913\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F191949\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F191939\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F191951\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F191950\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F191945\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F23601962\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Dietary Considerations\" href=\"#F191954\" class=\"outlineLink\">Dietary Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F191942\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F46103763\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/10132|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=medium-chain-triglycerides-patient-drug-information\" class=\"drug drug_patient\">Medium chain triglycerides: Patient drug information</a></li><li><a href=\"topic.htm?path=medium-chain-triglycerides-pediatric-drug-information\" class=\"drug drug_pediatric\">Medium chain triglycerides: Pediatric drug information</a></li></ul></div></div>","javascript":null}